1
|
Al-Tawfiq JA, Rodriguez-Morales AJ, Johani SA. The emergence of Oropouche virus in Cuba - A wake-up call for global health. J Infect Public Health 2024; 17:102513. [PMID: 39142079 DOI: 10.1016/j.jiph.2024.102513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2024] [Revised: 07/21/2024] [Accepted: 07/31/2024] [Indexed: 08/16/2024] Open
Affiliation(s)
- Jaffar A Al-Tawfiq
- Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indiana, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
| | - Alfonso J Rodriguez-Morales
- Faculty of Health Sciences, Universidad Científica del Sur, Lima 15067, Peru; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut 1102, Lebanon
| | - Sameera Al Johani
- King Abdulaziz Medical City, Department of Infection Prevention and Control, Riyadh, Saudi Arabia
| |
Collapse
|
2
|
Bertolino L, Patauner F, Durante-Mangoni E. Oropouche virus infection: What internal medicine physicians should know. Eur J Intern Med 2024:S0953-6205(24)00342-X. [PMID: 39127490 DOI: 10.1016/j.ejim.2024.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2024] [Accepted: 08/05/2024] [Indexed: 08/12/2024]
Abstract
Not required for Clinical Insight.
Collapse
Affiliation(s)
- Lorenzo Bertolino
- Department of Precision Medicine, University of Campania 'L. Vanvitelli', and Unit of Internal Medicine and Transplants, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy
| | - Fabian Patauner
- Department of Precision Medicine, University of Campania 'L. Vanvitelli', and Unit of Internal Medicine and Transplants, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy
| | - Emanuele Durante-Mangoni
- Department of Precision Medicine, University of Campania 'L. Vanvitelli', and Unit of Internal Medicine and Transplants, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy.
| |
Collapse
|
3
|
Scachetti GC, Forato J, Claro IM, Hua X, Salgado BB, Vieira A, Simeoni CL, Barbosa ARC, Rosa IL, de Souza GF, Fernandes LCN, de Sena ACH, Oliveira SC, Singh CML, de Lima ST, de Jesus R, Costa MA, Kato RB, Rocha JF, Santos LC, Rodrigues JT, Cunha MP, Sabino EC, Faria NR, Weaver SC, Romano CM, Lalwani P, Proença-Módena JL, de Souza WM. Reemergence of Oropouche virus between 2023 and 2024 in Brazil. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.07.27.24310296. [PMID: 39132482 PMCID: PMC11312653 DOI: 10.1101/2024.07.27.24310296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 08/13/2024]
Abstract
Background Oropouche virus (OROV; species Orthobunyavirus oropoucheense) is an arthropod-borne virus that has caused outbreaks of Oropouche fever in Central and South America since the 1950s. This study investigates virological factors contributing to the reemergence of Oropouche fever in Brazil between 2023 and 2024. Methods In this study, we combined OROV genomic, molecular, and serological data from Brazil from 1 January 2015 to 29 June 2024, along with in vitro and in vivo characterization. Molecular screening data included 93 patients with febrile illness between January 2023 and February 2024 from the Amazonas State. Genomic data comprised two genomic OROV sequences from patients. Serological data were obtained from neutralizing antibody tests comparing the prototype OROV strain BeAn 19991 and the 2024 epidemic strain. Epidemiological data included aggregated cases reported to the Brazilian Ministry of Health from 1 January 2014 to 29 June 2024. Findings In 2024, autochthonous OROV infections were detected in previously non-endemic areas across all five Brazilian regions. Cases were reported in 19 of 27 federal units, with 83.2% (6,895 of 8,284) of infections in Northern Brazil and a nearly 200-fold increase in incidence compared to reported cases over the last decade. We detected OROV RNA in 10.8% (10 of 93) of patients with febrile illness between December 2023 and May 2024 in Amazonas. We demonstrate that the 2023-2024 epidemic was caused by a novel OROV reassortant that replicated approximately 100-fold higher titers in mammalian cells compared to the prototype strain. The 2023-2024 OROV reassortant displayed plaques earlier than the prototype, produced 1.7 times more plaques, and plaque sizes were 2.5 larger compared to the prototype. Furthermore, serum collected in 2016 from previously OROV-infected individuals showed at least a 32-fold reduction in neutralizing capacity against the reassortment strain compared to the prototype. Interpretation These findings provide a comprehensive assessment of Oropouche fever in Brazil and contribute to a better understanding of the 2023-2024 OROV reemergence. The recent increased incidence may be related to a higher replication efficiency of a new reassortant virus that also evades previous immunity.
Collapse
Affiliation(s)
- Gabriel C. Scachetti
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Julia Forato
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Ingra M. Claro
- Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA
| | - Xinyi Hua
- Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA
| | - Bárbara B. Salgado
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - Aline Vieira
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Camila L. Simeoni
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Aguyda R. C. Barbosa
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - Italo L. Rosa
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - Gabriela F. de Souza
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Luana C. N. Fernandes
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - Ana Carla H. de Sena
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
- Universidade Federal do Amazonas, Manaus, Brazil
| | - Stephanne C. Oliveira
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - Carolina M. L. Singh
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
- Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil
| | - Shirlene T. de Lima
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
- Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA
- Laboratório Central de Saúde Pública do Ceará, Fortaleza, Brazil
| | - Ronaldo de Jesus
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Mariana A. Costa
- Laboratório Central de Saúde Pública do Acre, Rio Branco, Brazil
| | - Rodrigo B. Kato
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | | | | | | | - Marielton P. Cunha
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - Ester C. Sabino
- Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- Departamento de de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Nuno R. Faria
- Departamento de de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK
- Department of Zoology, University of Oxford, Oxford, UK
| | - Scott C. Weaver
- Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA
- World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, USA
| | - Camila M. Romano
- Departamento de de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Pritesh Lalwani
- Laboratory of Infectious Diseases and Immunology, Instituto Leônidas e Maria Deane, Fiocruz Amazônia, Manaus, Brazil
| | - José Luiz Proença-Módena
- Laboratory of Emerging Viruses, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil
| | - William M. de Souza
- Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA
| |
Collapse
|
4
|
Silva-Júnior EFD. Oropouche virus - The "Newest" invisible public enemy? Bioorg Med Chem 2024; 109:117797. [PMID: 38879995 DOI: 10.1016/j.bmc.2024.117797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2024] [Revised: 05/24/2024] [Accepted: 06/07/2024] [Indexed: 06/18/2024]
Abstract
This perspective underscores the rising challenge posed by emerging diseases against the backdrop of modern advancements in global public health understanding. It particularly highlights the emergence of the Oropouche virus (OROV) as a significant global threat, detailing its transmission dynamics, symptoms, and epidemiological impact, with a focus on its historical and current manifestations. It further delves into the molecular aspects of OROV, elucidating its unique characteristics, lack of structural similarity with other arboviruses, and the limited progress in medicinal chemistry research. Still, it highlights notable studies on potential antiviral agents and the challenges in drug development, emphasizing the need for innovative approaches such as structure-based drug design (SBDD) and drug repurposing. Finally, it concludes with a call to action, urging increased attention and research focus on OROV to prevent potential future pandemics fueled by viral mutations.
Collapse
Affiliation(s)
- Edeildo Ferreira da Silva-Júnior
- Research Group of Biological and Molecular Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Lourival Melo Mota Avenue, AC. Simões Campus, 57072-970 Alagoas, Maceió, Brazil.
| |
Collapse
|
5
|
Wesselmann KM, Postigo-Hidalgo I, Pezzi L, de Oliveira-Filho EF, Fischer C, de Lamballerie X, Drexler JF. Emergence of Oropouche fever in Latin America: a narrative review. THE LANCET. INFECTIOUS DISEASES 2024; 24:e439-e452. [PMID: 38281494 DOI: 10.1016/s1473-3099(23)00740-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Revised: 11/18/2023] [Accepted: 11/20/2023] [Indexed: 01/30/2024]
Abstract
Since its discovery in 1955, the incidence and geographical spread of reported Oropouche virus (OROV) infections have increased. Oropouche fever has been suggested to be one of the most important vector-borne diseases in Latin America. However, both literature on OROV and genomic sequence availability are scarce, with few contributing laboratories worldwide. Three reassortant OROV glycoprotein gene variants termed Iquitos, Madre de Dios, and Perdões virus have been described from humans and non-human primates. OROV predominantly causes acute febrile illness, but severe neurological disease such as meningoencephalitis can occur. Due to unspecific symptoms, laboratory diagnostics are crucial. Several laboratory tests have been developed but robust commercial tests are hardly available. Although OROV is mainly transmitted by biting midges, it has also been detected in several mosquito species and a wide range of vertebrate hosts, which likely facilitates its widespread emergence. However, potential non-human vertebrate reservoirs have not been systematically studied. Robust animal models to investigate pathogenesis and immune responses are not available. Epidemiology, pathogenesis, transmission cycle, cross-protection from infections with OROV reassortants, and the natural history of infection remain unclear. This Review identifies Oropouche fever as a neglected disease and offers recommendations to address existing knowledge gaps, enable risk assessments, and ensure effective public health responses.
Collapse
Affiliation(s)
- Konrad M Wesselmann
- Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France
| | - Ignacio Postigo-Hidalgo
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Laura Pezzi
- Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France; Centre National de Référence (CNR) des Arbovirus, Marseille, France
| | - Edmilson F de Oliveira-Filho
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Carlo Fischer
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Xavier de Lamballerie
- Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France; Centre National de Référence (CNR) des Arbovirus, Marseille, France
| | - Jan Felix Drexler
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Centre for Infection Research (DZIF), Berlin, Germany.
| |
Collapse
|
6
|
de Lima RC, Dias HG, de Souza TMA, Familiar-Macedo D, Ribeiro ED, Corrêa VCE, Pauvolid-Corrêa A, de Azeredo EL, dos Santos FB. Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil. Pathogens 2024; 13:469. [PMID: 38921767 PMCID: PMC11206884 DOI: 10.3390/pathogens13060469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Revised: 04/21/2024] [Accepted: 05/02/2024] [Indexed: 06/27/2024] Open
Abstract
Oropouche orthobunyavirus (OROV) is an arbovirus transmitted by midges that has been involved in outbreaks throughout Central and South America. In Brazil, human cases have been historically concentrated in the northern region of the country. Oropouche fever in humans range from mild clinical signs to rare neurological events, and is considered a neglected tropical disease in Brazil. Due to the clinical similarities to other arboviruses, such as chikungunya and dengue viruses, OROV infections are likely to be underreported. Chikungunya virus (CHIKV) cases in Brazil were first recognized in 2014 in the states of Amapá and Bahia in the north and northeast regions, respectively. Both OROV and CHIKV cause nonspecific symptoms, making clinical diagnosis difficult in a scenario of arbovirus cocirculation. Aiming to investigate OROV transmission during the CHIKV introduction in the state of Amapá located in the Brazilian Amazon, we conducted a retrospective molecular (RT-qPCR) and serological investigation in febrile cases (N = 166) collected between August 2014 and May 2015. All acute serum samples were negative for OROV RNA using RT-qPCR. However, neutralizing antibodies for OROV were detected using a plaque reduction neutralization test (PRNT90) in 10.24% (17/166) of the patients, with neutralizing antibody titers ranging from 20 to ≥640, suggesting the previous exposure of patients to OROV. Regarding CHIKV, recent exposure was confirmed by the detection of CHIKV RNA in 20.25% (33/163) of the patients and by the detection of anti-CHIKV IgM in 28.57% (44/154) of the patients. The additional detection of anti-CHIKV IgG in 12.58% (19/151) of the febrile patients suggests that some individuals had been previously exposed to CHIKV. Whether the OROV exposure reported here occurred prior or during the CHIKV circulation in Amapá, is unknown, but because those arboviral infections share similar clinical signs and symptoms, a silent circulation of enzootic arboviruses during the introduction of exotic arboviruses may occur, and highlights the importance of syndromic cases' surveillance to arboviruses in Brazil.
Collapse
Affiliation(s)
- Raquel Curtinhas de Lima
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| | - Helver Gonçalves Dias
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| | - Thiara Manuele Alves de Souza
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| | - Débora Familiar-Macedo
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| | | | | | - Alex Pauvolid-Corrêa
- Laboratório de Virologia Veterinária de Viçosa, Departamento de Veterinária, Universidade Federal de Viçosa (UFV), Viçosa 36570-900, Brazil;
| | - Elzinandes Leal de Azeredo
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| | - Flávia Barreto dos Santos
- Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil; (R.C.d.L.); (H.G.D.); (T.M.A.d.S.); (D.F.-M.); (E.L.d.A.)
| |
Collapse
|
7
|
Mohapatra RK. Surging Oropouche virus (OROV) cases in the Americas: A public health challenge. New Microbes New Infect 2024; 59:101243. [PMID: 38586178 PMCID: PMC10995965 DOI: 10.1016/j.nmni.2024.101243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2024] [Revised: 03/22/2024] [Accepted: 03/25/2024] [Indexed: 04/09/2024] Open
Affiliation(s)
- Ranjan K. Mohapatra
- Department of Chemistry, Government College of Engineering, Keonjhar, 758 002, Odisha, India
| |
Collapse
|
8
|
Andreolla AP, Borges AA, Nagashima S, Vaz de Paula CB, de Noronha L, Zanchin NIT, Bordignon J, Duarte Dos Santos CN. Development of monoclonal antibodies against oropouche virus and its applicability to immunohistochemical diagnosis. Virol J 2024; 21:81. [PMID: 38589896 PMCID: PMC11000289 DOI: 10.1186/s12985-024-02323-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Accepted: 02/21/2024] [Indexed: 04/10/2024] Open
Abstract
Orthobunyavirus oropouche ense virus (OROV), the causative agent of Oropouche fever, is widely dispersed in Brazil and South America, causing sporadic outbreaks. Due to the similarity of initial clinical symptoms caused by OROV with other arboviruses found in overlapping geographical areas, differential diagnosis is challenging. As for most neglected tropical diseases, there is a shortage of reagents for diagnosing and studying OROV pathogenesis. We therefore developed and characterized mouse monoclonal antibodies and, one of them recognizes the OROV nucleocapsid in indirect immunofluorescent (IFA) and immunohistochemistry (IHC) assays. Considering that it is the first monoclonal antibody produced for detecting OROV infections, we believe that it will be useful not only for diagnostic purposes but also for performing serological surveys and epidemiological surveillance on the dispersion and prevalence of OROV in Brazil and South America.
Collapse
Affiliation(s)
- Ana Paula Andreolla
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, ICC/Fiocruz PR, Cidade Industrial de Curitiba, Rua Prof. Algacyr Munhoz Mader 3775, Curitiba, Paraná, Brazil
| | - Alessandra Abel Borges
- Laboratório de Pesquisas em Virologia e Imunologia, Instituto de Ciências Biológicas e da Saúde (ICBS), Universidade Federal de Alagoas (UFAL), Av. Lourival Melo Mota, s/n, Tabuleiro do Martins, Maceió, Alagoas, Brazil
| | - Seigo Nagashima
- Laboratório de Patologia Experimental, Pontifica Universidade Católica do Paraná (PUC/PR), Rua Imaculada Conceição, 1155, Prado Velho, Curitiba, Paraná, Brazil
| | - Caroline Busatta Vaz de Paula
- Laboratório de Patologia Experimental, Pontifica Universidade Católica do Paraná (PUC/PR), Rua Imaculada Conceição, 1155, Prado Velho, Curitiba, Paraná, Brazil
| | - Lucia de Noronha
- Laboratório de Patologia Experimental, Pontifica Universidade Católica do Paraná (PUC/PR), Rua Imaculada Conceição, 1155, Prado Velho, Curitiba, Paraná, Brazil
| | - Nilson I T Zanchin
- Laboratório de Biologia Estrutural e Engenharia de Proteínas, Instituto Carlos Chagas, ICC/Fiocruz PR, Cidade Industrial de Curitiba, Rua Prof. Algacyr Munhoz Mader 3775, Curitiba, Paraná, Brazil
| | - Juliano Bordignon
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, ICC/Fiocruz PR, Cidade Industrial de Curitiba, Rua Prof. Algacyr Munhoz Mader 3775, Curitiba, Paraná, Brazil.
| | - Claudia Nunes Duarte Dos Santos
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, ICC/Fiocruz PR, Cidade Industrial de Curitiba, Rua Prof. Algacyr Munhoz Mader 3775, Curitiba, Paraná, Brazil.
| |
Collapse
|
9
|
Moreira HM, Sgorlon G, Queiroz JAS, Roca TP, Ribeiro J, Teixeira KS, Passos-Silva AM, Araújo A, Gasparelo NWF, Dos Santos ADO, Lugtenburg CAB, Roque RA, Villalobos Salcedo JM, Pereira DB, Vieira D. Outbreak of Oropouche virus in frontier regions in western Amazon. Microbiol Spectr 2024; 12:e0162923. [PMID: 38323826 PMCID: PMC10913433 DOI: 10.1128/spectrum.01629-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 11/21/2023] [Indexed: 02/08/2024] Open
Abstract
Oropouche virus (OROV) is characterized as a re-emerging arbovirus of great concern for public health, being responsible for several outbreaks of acute fever identified in Latin American countries, registering more than half a million reported cases. The incidence of reports of this virus is intrinsically favored by environmental conditions, in which such characteristics are related to the increase and distribution of the vector population to areas of human traffic. Moreover, there is a problem regarding the lack of diagnosis in Brazil that aggregates the success of the etiologic agent. Thus, by means of molecular techniques, we identified 27 positive cases of the OROV circulating in border locations in western Amazon, with 44.44% (12/27) of the cohort characterized as infected individuals with reported symptoms, mainly ranging from fever, myalgia, and back pain. Among the positive samples, it was possible to obtain a total of 48.14% (13/27) samples to analyze the S and M segments of Oropouche, which showed similarities among the Brazilian sequences. Thus, it was possible to verify the circulation of the OROV in Rondonia and border areas, in which the tracking of neglected arboviruses is necessary for the genomic surveillance of emerging and re-emerging viruses.IMPORTANCEThe western Amazon region is known for outbreaks of acute febrile illnesses, to which the lack of specific diagnostics for different pathogens hinders the management of patients in healthcare units. The Oropouche virus has already been recorded in the region in the 1990s. However, this is the first study, after this record, to perform the detection of individuals with acute febrile illness using a screening test to exclude Zika, dengue, and chikungunya, confirmed by sequencing the circulation of the virus in the state of Rondonia and border areas. We emphasize the importance of including diagnostics for viruses such as Oropouche, which suffers underreporting for years and is related to seasonal periods in Western Amazon locations, a factor that has a direct influence on public health in the region. In addition, we emphasize the importance of genomic surveillance in the elucidation of outbreaks that affect the resident population of these locations.
Collapse
Affiliation(s)
- Hillquias Monteiro Moreira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Gabriella Sgorlon
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Jackson A. S. Queiroz
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Tarcio P. Roca
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Jessiane Ribeiro
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Karolaine S. Teixeira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Ana Maísa Passos-Silva
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Adrhyan Araújo
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Nadson Willian Felipe Gasparelo
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | | | | | | | | | - Dhelio B. Pereira
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| | - Deusilene Vieira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondonia - FIOCRUZ/RO, Porto Velho, Rondonia, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondonia - UNIR, Porto Velho, Rondonia, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, Rondonia, Brazil
| |
Collapse
|
10
|
Zhang Y, Liu X, Wu Z, Feng S, Lu K, Zhu W, Sun H, Niu G. Oropouche virus: A neglected global arboviral threat. Virus Res 2024; 341:199318. [PMID: 38224842 PMCID: PMC10827532 DOI: 10.1016/j.virusres.2024.199318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2023] [Revised: 01/02/2024] [Accepted: 01/12/2024] [Indexed: 01/17/2024]
Abstract
The Oropouche virus is an important arthropod-borne virus in the Peribunyaviridae family that can cause febrile illnesses, and it is widely distributed in tropical regions such as Central and South America. Since the virus was first identified, a large number of related cases are reported every year. No deaths have been reported to date, however, the virus can cause systemic infections, including the nervous and blood systems, leading to serious complications. The transmission of Oropouche virus occurs through both urban and sylvatic cycles, with the anthropophilic biting midge Culicoides paraensis serving as the primary vector in urban areas. Direct human-to-human transmission of Oropouche virus has not been observed. Oropouche virus consists of three segments, and the proteins encoded by the different segments enables the virus to replicate efficiently in the host and to resist the host's immune response. Phylogenetic analyses showed that Oropouche virus sequences are geographically distinct and have closer homologies with Iquitos virus and Perdoes virus, which belong to the family Peribunyaviridae. Despite the enormous threat it poses to public health, there are currently no licensed vaccines or specific antiviral treatments for the disease it causes. Recent studies have utilised imJatobal virusmunoinformatics approaches to develop epitope-based peptide vaccines, which have laid the groundwork for the clinical use of vaccines. The present review focuses on the structure, epidemiology, immunity and phylogeny of Oropouche virus, as well as the progress of vaccine development, thereby attracting wider attention and research, particularly with regard to potential vaccine programs.
Collapse
Affiliation(s)
- Yuli Zhang
- Shandong Second Medical University, Weifang, 261053, China
| | - Xiao Liu
- Shandong Second Medical University, Weifang, 261053, China
| | - Zhen Wu
- Shandong Second Medical University, Weifang, 261053, China
| | - Shuo Feng
- Shandong Second Medical University, Weifang, 261053, China
| | - Ke Lu
- Shandong Second Medical University, Weifang, 261053, China
| | - Wenbing Zhu
- Shandong Second Medical University, Weifang, 261053, China
| | - Hengyi Sun
- Shandong Second Medical University, Weifang, 261053, China.
| | - Guoyu Niu
- Shandong Second Medical University, Weifang, 261053, China.
| |
Collapse
|
11
|
Chitre SD, Crews CM, Tessema MT, Plėštytė-Būtienė I, Coffee M, Richardson ET. The impact of anthropogenic climate change on pediatric viral diseases. Pediatr Res 2024; 95:496-507. [PMID: 38057578 PMCID: PMC10872406 DOI: 10.1038/s41390-023-02929-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 10/12/2023] [Accepted: 11/16/2023] [Indexed: 12/08/2023]
Abstract
The adverse effects of climate change on human health are unfolding in real time. Environmental fragmentation is amplifying spillover of viruses from wildlife to humans. Increasing temperatures are expanding mosquito and tick habitats, introducing vector-borne viruses into immunologically susceptible populations. More frequent flooding is spreading water-borne viral pathogens, while prolonged droughts reduce regional capacity to prevent and respond to disease outbreaks with adequate water, sanitation, and hygiene resources. Worsening air quality and altered transmission seasons due to an increasingly volatile climate may exacerbate the impacts of respiratory viruses. Furthermore, both extreme weather events and long-term climate variation are causing the destruction of health systems and large-scale migrations, reshaping health care delivery in the face of an evolving global burden of viral disease. Because of their immunological immaturity, differences in physiology (e.g., size), dependence on caregivers, and behavioral traits, children are particularly vulnerable to climate change. This investigation into the unique pediatric viral threats posed by an increasingly inhospitable world elucidates potential avenues of targeted programming and uncovers future research questions to effect equitable, actionable change. IMPACT: A review of the effects of climate change on viral threats to pediatric health, including zoonotic, vector-borne, water-borne, and respiratory viruses, as well as distal threats related to climate-induced migration and health systems. A unique focus on viruses offers a more in-depth look at the effect of climate change on vector competence, viral particle survival, co-morbidities, and host behavior. An examination of children as a particularly vulnerable population provokes programming tailored to their unique set of vulnerabilities and encourages reflection on equitable climate adaptation frameworks.
Collapse
Affiliation(s)
- Smit D Chitre
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
| | - Cecilia M Crews
- Heilbrunn Department of Population & Family Health, Columbia University Mailman School of Public Health, New York, NY, USA
| | - Mesfin Teklu Tessema
- Heilbrunn Department of Population & Family Health, Columbia University Mailman School of Public Health, New York, NY, USA.
- International Rescue Committee, New York, NY, USA.
| | | | - Megan Coffee
- Heilbrunn Department of Population & Family Health, Columbia University Mailman School of Public Health, New York, NY, USA
- International Rescue Committee, New York, NY, USA
- New York University Grossman School of Medicine, New York, NY, USA
| | - Eugene T Richardson
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| |
Collapse
|
12
|
Kampen H, Werner D. Biting Midges (Diptera: Ceratopogonidae) as Vectors of Viruses. Microorganisms 2023; 11:2706. [PMID: 38004718 PMCID: PMC10673010 DOI: 10.3390/microorganisms11112706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 10/30/2023] [Accepted: 11/02/2023] [Indexed: 11/26/2023] Open
Abstract
Biting midges of the genus Culicoides occur almost globally and can regionally and seasonally reach high abundances. Most species are hematophagous, feeding on all groups of vertebrates, including humans. In addition to being nuisance pests, they are able to transmit disease agents, with some viruses causing high morbidity and/or mortality in ruminants, horses and humans. Despite their impact on animal husbandry, public health and tourism, knowledge on the biology and ecology of culicoid biting midges and their interactions with ingested pathogens or symbiotic microorganisms is limited. Research is challenging due to unknown larval habitats, the insects' tiny size, the inability to establish and breed most species in the laboratory and the laborious maintenance of colonies of the few species that can be reared in the laboratory. Consequently, the natural transmission of pathogens has experimentally been demonstrated for few species while, for others, only indirect evidence of vector potential exists. Most experimental data are available for Culicoides sonorensis and C. nubeculosus, the only species kept in western-world insectaries. This contribution gives an overview on important biting midge vectors, transmitted viruses, culicoid-borne viral diseases and their epidemiologies and summarizes the little knowledge on interactions between biting midges, their microflora and culicoid-borne arboviruses.
Collapse
Affiliation(s)
- Helge Kampen
- Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald, Germany
| | - Doreen Werner
- Leibniz Centre for Agricultural Landscape Research, 15374 Muencheberg, Germany;
| |
Collapse
|
13
|
Hartman AL, Myler PJ. Bunyavirales: Scientific Gaps and Prototype Pathogens for a Large and Diverse Group of Zoonotic Viruses. J Infect Dis 2023; 228:S376-S389. [PMID: 37849397 PMCID: PMC10582323 DOI: 10.1093/infdis/jiac338] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2023] Open
Abstract
Research directed at select prototype pathogens is part of the approach put forth by the National Institute of Allergy and Infectious Disease (NIAID) to prepare for future pandemics caused by emerging viruses. We were tasked with identifying suitable prototypes for four virus families of the Bunyavirales order (Phenuiviridae, Peribunyaviridae, Nairoviridae, and Hantaviridae). This is a challenge due to the breadth and diversity of these viral groups. While there are many differences among the Bunyavirales, they generally have complex ecological life cycles, segmented genomes, and cause a range of human clinical outcomes from mild to severe and even death. Here, we delineate potential prototype species that encompass the breadth of clinical outcomes of a given family, have existing reverse genetics tools or animal disease models, and can be amenable to a platform approach to vaccine testing. Suggested prototype pathogens outlined here can serve as a starting point for further discussions.
Collapse
Affiliation(s)
- Amy L Hartman
- Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA
| | - Peter J Myler
- Department of Pediatrics and the Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA
- Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, Washington, USA
| |
Collapse
|
14
|
Ali I, Alarcόn-Elbal PM, Mundle M, Noble SAA, Oura CAL, Anzinger JJ, Sandiford SL. The Others: A Systematic Review of the Lesser-Known Arboviruses of the Insular Caribbean. Viruses 2023; 15:843. [PMID: 37112824 PMCID: PMC10144105 DOI: 10.3390/v15040843] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 03/16/2023] [Accepted: 03/20/2023] [Indexed: 03/29/2023] Open
Abstract
The Caribbean enjoys a long-standing eminence as a popular tourist destination; however, over the years it has also amassed the sobriquet "arbovirus hotspot". As the planet warms and vectors expand their habitats, a cognizant working knowledge of the lesser-known arboviruses and the factors that influence their emergence and resurgence becomes essential. The extant literature on Caribbean arboviruses is spread across decades of published literature and is quite often difficult to access, and, in some cases, is obsolete. Here, we look at the lesser-known arboviruses of the insular Caribbean and examine some of the drivers for their emergence and resurgence. We searched the scientific literature databases PubMed and Google Scholar for peer-reviewed literature as well as scholarly reports. We included articles and reports that describe works resulting in serological evidence of the presence of arboviruses and/or arbovirus isolations in the insular Caribbean. Studies without serological evidence and/or arbovirus isolations as well as those including dengue, chikungunya, Zika, and yellow fever were excluded. Of the 545 articles identified, 122 met the inclusion criteria. A total of 42 arboviruses were identified in the literature. These arboviruses and the drivers that affect their emergence/resurgence are discussed.
Collapse
Affiliation(s)
- Inshan Ali
- Department of Microbiology, Faculty of Medical Sciences, The University of the West Indies, Mona, Kingston 7, Jamaica
| | - Pedro M. Alarcόn-Elbal
- Department of Animal Production and Health, Veterinary Public Health and Food Science and Technology (PASAPTA), Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain
| | - Marcia Mundle
- Department of Natural Sciences, Faculty of Science and Technology, The Mico University College, Kingston 5, Jamaica
| | - Simmoy A. A. Noble
- Department of Microbiology, Faculty of Medical Sciences, The University of the West Indies, Mona, Kingston 7, Jamaica
| | - Chris A. L. Oura
- School of Veterinary Medicine, Faculty of Medical Sciences, The University of the West Indies, St. Augustine 685509, Trinidad and Tobago
| | - Joshua J. Anzinger
- Department of Microbiology, Faculty of Medical Sciences, The University of the West Indies, Mona, Kingston 7, Jamaica
- Global Virus Network, Baltimore, MD 21201, USA
| | - Simone L. Sandiford
- Department of Basic Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, Mona, Kingston 7, Jamaica
- Mosquito Control and Research Unit, The University of the West Indies, Mona, Kingston 7, Jamaica
| |
Collapse
|
15
|
Ciuoderis KA, Berg MG, Perez LJ, Hadji A, Perez-Restrepo LS, Aristizabal LC, Forberg K, Yamaguchi J, Cardona A, Weiss S, Qiu X, Hernandez-Ortiz JP, Averhoff F, Cloherty GA, Osorio JE. Oropouche virus as an emerging cause of acute febrile illness in Colombia. Emerg Microbes Infect 2022; 11:2645-2657. [PMID: 36239235 PMCID: PMC9639516 DOI: 10.1080/22221751.2022.2136536] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Arbovirus infections are frequent causes of acute febrile illness (AFI) in tropical countries. We conducted health facility-based AFI surveillance at four sites in Colombia (Cucuta, Cali, Villavicencio, Leticia) during 2019-2022. Demographic, clinical and risk factor data were collected from persons with AFI that consented to participate in the study (n = 2,967). Serologic specimens were obtained and tested for multiple pathogens by RT-PCR and rapid test (Antigen/IgM), with 20.7% identified as dengue positive from combined testing. Oropouche virus (OROV) was initially detected in serum by metagenomic next-generation sequencing (mNGS) and virus target capture in a patient from Cúcuta. Three additional infections from Leticia were confirmed by conventional PCR, sequenced, and isolated in tissue culture. Phylogenetic analysis determined there have been at least two independent OROV introductions into Colombia. To assess OROV spread, a RT-qPCR dual-target assay was developed which identified 87/791 (10.9%) viremic cases in AFI specimens from Cali (3/53), Cucuta (3/19), Villavicencio (38/566), and Leticia (43/153). In parallel, an automated anti-nucleocapsid antibody assay detected IgM in 27/503 (5.4%) and IgG in 92/568 (16.2%) patients screened, for which 24/68 (35.3%) of PCR positives had antibodies. Dengue was found primarily in people aged <18 years and linked to several clinical manifestations (weakness, skin rash and petechiae), whereas Oropouche cases were associated with the location, climate phase, and odynophagia symptom. Our results confirm OROV as an emerging pathogen and recommend increased surveillance to determine its burden as a cause of AFI in Colombia.
Collapse
Affiliation(s)
- Karl A. Ciuoderis
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA, Karl A Ciuoderis Colombia/Wisconsin One Health Consortium (CWOHC), Universidad Nacional de Colombia, Medellín, ColombiaAbbott Pandemic Defense Coalition
| | - Michael G. Berg
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Lester J. Perez
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Abbas Hadji
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Laura S. Perez-Restrepo
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Leidi Carvajal Aristizabal
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Kenn Forberg
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Julie Yamaguchi
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Andres Cardona
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Sonja Weiss
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Xiaoxing Qiu
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Juan Pablo Hernandez-Ortiz
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Francisco Averhoff
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Gavin A. Cloherty
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Jorge E. Osorio
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Global Health Institute, University of Wisconsin, Madison, WI, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| |
Collapse
|